AR126029A1 - LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1) - Google Patents
LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1)Info
- Publication number
- AR126029A1 AR126029A1 ARP210103150A ARP210103150A AR126029A1 AR 126029 A1 AR126029 A1 AR 126029A1 AR P210103150 A ARP210103150 A AR P210103150A AR P210103150 A ARP210103150 A AR P210103150A AR 126029 A1 AR126029 A1 AR 126029A1
- Authority
- AR
- Argentina
- Prior art keywords
- multimeric binding
- tfr1
- peptide
- peptide ligands
- peptide ligand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2017927.1A GB202017927D0 (en) | 2020-11-13 | 2020-11-13 | Bicyclic peptide ligands specific for transferrin |
| GBGB2106903.4A GB202106903D0 (en) | 2021-05-14 | 2021-05-14 | Bicycle peptide ligands specific for transferrin |
| US202163261820P | 2021-09-29 | 2021-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126029A1 true AR126029A1 (es) | 2023-09-06 |
Family
ID=81600834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103150A AR126029A1 (es) | 2020-11-13 | 2021-11-12 | LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1) |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11970555B2 (https=) |
| EP (1) | EP4244235A1 (https=) |
| JP (1) | JP7848202B2 (https=) |
| KR (1) | KR20230107589A (https=) |
| CN (1) | CN116802190A (https=) |
| AR (1) | AR126029A1 (https=) |
| AU (1) | AU2021376917A1 (https=) |
| CA (1) | CA3201414A1 (https=) |
| IL (1) | IL302713A (https=) |
| MX (1) | MX2023005624A (https=) |
| SA (1) | SA523440745B1 (https=) |
| WO (1) | WO2022101633A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230107589A (ko) | 2020-11-13 | 2023-07-17 | 바이사이클티엑스 리미티드 | 트랜스페린 수용체 1 (TfR1)에 특이적인 비시클릭 펩티드 리간드 |
| GB202206431D0 (en) * | 2022-05-03 | 2022-06-15 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
| EP4689119A1 (en) * | 2023-04-05 | 2026-02-11 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing pln expression |
| WO2025073871A1 (en) | 2023-10-03 | 2025-04-10 | Bicycletx Limited | Bicyclic peptide ligand complexes specific for tfr1 |
| GB202316970D0 (en) * | 2023-11-06 | 2023-12-20 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2653545A1 (en) | 2008-02-05 | 2013-10-23 | Bicycle Therapeutics Limited | Methods and compositions |
| GB0914110D0 (en) | 2009-08-12 | 2009-09-16 | Medical Res Council | Peptide libraries |
| EP3218411B1 (en) * | 2014-11-14 | 2022-01-12 | Ossianix, Inc. | Variable new antigen receptors (vnars) directed against transferrin receptor (tfr) and their use |
| CN104650186A (zh) | 2015-03-09 | 2015-05-27 | 中国药科大学 | 一种能够与TfR1特异性结合的活性肽及其应用 |
| GB201706477D0 (en) * | 2017-04-24 | 2017-06-07 | Bicycle Therapeutics Ltd | Modification of polypeptides |
| US10857196B2 (en) * | 2017-04-27 | 2020-12-08 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Ｃｄ１３７に対して特異的な二環式ペプチドリガンド |
| WO2019089395A1 (en) | 2017-11-02 | 2019-05-09 | Ossianix, Inc. | Improved tfr-selective binding peptides capable of crossing the blood brain barrier |
| CN111902429A (zh) | 2018-02-23 | 2020-11-06 | 拜斯科技术开发有限公司 | 多聚体双环肽配体 |
| WO2020084305A1 (en) | 2018-10-23 | 2020-04-30 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| US12492224B2 (en) * | 2018-12-21 | 2025-12-09 | Bicycletx Limited | Bicyclic peptide ligands specific for PD-L1 |
| GB201912320D0 (en) * | 2019-08-28 | 2019-10-09 | Bicycletx Ltd | PBP Binding Bicyclic Peptide Ligands |
| KR20230107589A (ko) | 2020-11-13 | 2023-07-17 | 바이사이클티엑스 리미티드 | 트랜스페린 수용체 1 (TfR1)에 특이적인 비시클릭 펩티드 리간드 |
-
2021
- 2021-11-12 KR KR1020237017137A patent/KR20230107589A/ko active Pending
- 2021-11-12 AU AU2021376917A patent/AU2021376917A1/en active Pending
- 2021-11-12 IL IL302713A patent/IL302713A/en unknown
- 2021-11-12 EP EP21819173.2A patent/EP4244235A1/en active Pending
- 2021-11-12 CA CA3201414A patent/CA3201414A1/en active Pending
- 2021-11-12 AR ARP210103150A patent/AR126029A1/es unknown
- 2021-11-12 JP JP2023528449A patent/JP7848202B2/ja active Active
- 2021-11-12 WO PCT/GB2021/052927 patent/WO2022101633A1/en not_active Ceased
- 2021-11-12 MX MX2023005624A patent/MX2023005624A/es unknown
- 2021-11-12 US US17/454,665 patent/US11970555B2/en active Active
- 2021-11-12 CN CN202180089518.5A patent/CN116802190A/zh active Pending
-
2023
- 2023-05-11 SA SA523440745A patent/SA523440745B1/ar unknown
-
2024
- 2024-03-19 US US18/610,009 patent/US20240391959A1/en not_active Abandoned
-
2025
- 2025-04-23 US US19/187,619 patent/US20250340595A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022101633A1 (en) | 2022-05-19 |
| AU2021376917A1 (en) | 2023-06-29 |
| IL302713A (en) | 2023-07-01 |
| JP2023549229A (ja) | 2023-11-22 |
| EP4244235A1 (en) | 2023-09-20 |
| US20250340595A1 (en) | 2025-11-06 |
| JP7848202B2 (ja) | 2026-04-20 |
| MX2023005624A (es) | 2023-05-24 |
| US20220194988A1 (en) | 2022-06-23 |
| AU2021376917A9 (en) | 2024-09-12 |
| CN116802190A (zh) | 2023-09-22 |
| SA523440745B1 (ar) | 2024-07-24 |
| US20240391959A1 (en) | 2024-11-28 |
| US11970555B2 (en) | 2024-04-30 |
| KR20230107589A (ko) | 2023-07-17 |
| CA3201414A1 (en) | 2022-05-19 |
| TW202233664A (zh) | 2022-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR126029A1 (es) | LIGANDOS DE PÉPTIDOS BICÍCLICOS ESPECÍFICOS PARA EL RECEPTOR DE TRANSFERRINA 1 (TfR1) | |
| MX2025001638A (es) | Ligandos de peptidos biciclicos especificos para nectina-4 | |
| HRP20250841T1 (hr) | Heterotandemski biciklični peptidni kompleksi | |
| MX2021013669A (es) | Ligandos peptidicos biciclicos especificos para ox40. | |
| JP2022542386A5 (https=) | ||
| MX2020006474A (es) | Ligandos de peptidos biciclicos especificos para el receptor eph de tirosina quinasa a2 (epha2). | |
| SA520420008B1 (ar) | جزيئات ترابطية ببتيدية ثنائية الحلقات متعددة الوحدات | |
| JP2022544058A5 (https=) | ||
| JP2022542286A5 (https=) | ||
| AR064555A1 (es) | Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo | |
| CN107106642B (zh) | 拟肽大环化合物及其制剂 | |
| PE20181852A1 (es) | Profarmacos de farmacos citotoxicos que tienen grupos enzimaticamente escindibles | |
| BR112022007099A2 (pt) | Conjugados de fármaco de ligante de peptídeo bicíclico | |
| JP2018503668A5 (https=) | ||
| WO2022148974A3 (en) | Bicyclic peptide ligands specific for nk cells | |
| AR080863A1 (es) | Derivados del acido1-amino-2-ciclopropiletilboronico, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer. | |
| US10039807B2 (en) | bFGF-polymer conjugates, methods for making the same and applications thereof | |
| EA202092646A1 (ru) | Происходящие из pedf пептиды для промотирования регенерации мейбомиевой железы и их применения | |
| AR115601A1 (es) | Ligandos peptídicos bicíclicos específicos para nectina-4 | |
| EA202190104A1 (ru) | Бициклические пептидные лиганды, специфичные к нектину-4 | |
| TH2001007117A (th) | ลิแกนด์ เปปไทด์ ไบไซคลิกที่จำเพาะสำหรับเนคทิน-4 | |
| EA202091991A1 (ru) | Мультимерные бициклические пептидные лиганды | |
| EA202191660A1 (ru) | Бициклические пептидные лиганды, специфичные к mt1-mmp | |
| EA202091375A1 (ru) | БИЦИКЛИЧЕСКИЕ ПЕПТИДНЫЕ ЛИГАНДЫ, ОБЛАДАЮЩИЕ СПЕЦИФИЧНОСТЬЮ К EphA2 | |
| MX2016004660A (es) | Composiciones de peptido novedosas. |